Updates are available Correction dated 2022-12-20

Article History

Accepted: 12 October 2022

First Online: 23 November 2022

Change Date: 20 December 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40266-022-00996-1

Declarations

:

: As principal investigator, ER had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: ER, GD, NPN, LB, NP, TLK. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: GD, ER, NPN, TLK. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: GD, NPN, ER, NP, TLK. Obtained funding: ER, DR, LKE, LB, NP, Parfitt, JW, RL. Administrative, technical, or material support: GD, ER, RLB, NP, TLK, AA, RL. Supervision: ER

: This work was supported by the Australian Government Department of Health Pharmacy Trial Program. The Australian Government Department of Health reviewed the manuscript before submission but played no role in the study design, data collection, management, writing of the manuscript or decision to submit the paper for publication.

: De-identified data and codes can be requested from the corresponding author.

: Gereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, Thu-Lan Kelly, Nicole Pratt, Lisa Kalisch-Ellet, Andre Andrade, Debra Rowett, Joseph Whitehouse, Rebecca L. Bilton, Renly Lim, Imaina Widagdo and Elizabeth Roughead have no conflicts of interest to declare.

: This study was approved by the Human Research Ethics Committee of the University of South Australia (ID: 0000036440) and the University of Tasmania (ID: H0017022).

: Not applicable.

: Not applicable.

: Not required for publication.